Tag: tax credits

December 10, 2018

Cleantech Outlook 2019: “Important Year” Ahead

While 2018 proved to be a challenge for the cleantech sector, 2019 is set to redefine the space in both...
May 10, 2018

Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma

Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of...
March 29, 2018

Cynata Therapeutics Receives Orphan Drug Designation from FDA

The orphan drug designation is a unique mission that incentivizes companies to develop treatments for the rare disease market.
March 15, 2018

Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis

Proteostasis Therapeutics (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic...
March 14, 2018

Tetra Bio-Pharma Gets FDA Orphan Drug Designation for PPP001

Tetra Bio-Pharma announced that the FDA granted an orphan drug designation to the active ingredients of its PPP001 drug treating...
February 14, 2018

US Extends Deadline for Nuclear Tax Credits

The extension is seen as essential to the completion of US nuclear power plants already under construction, and for small...
December 19, 2017

Cleantech Outlook 2018: Renewables at the Forefront

2017 posed some challenges as well as hope in the cleantech industry in the midst of political uncertainty. As we...